anonymous
Guest
anonymous
Guest
This product will plummet aflibercept sales some what? Data for it looks good, is Eylea in more trouble that people think? I know renting specialists are looking for a more durable molecule and brolucizumab might be it. Projections are that Eylea is going to have it's lunch eaten.